Oct 19 2006
Lester Crawford, who resigned as FDA commissioner in September 2005, on Tuesday pleaded guilty in U.S. District Court to charges of false reporting and conflicts of interest related to ownership of stocks in companies that are regulated by the agency, the AP/Philadelphia Inquirer reports (Bridges, AP/Philadelphia Inquirer, 10/18).
On Monday, the Department of Justice charged Crawford with the two misdemeanors, each of which carries a maximum penalty of one year in prison.
Barbara Van Gelder, Crawford's attorney, said she expects him to be fined and placed on probation.
DOJ said Crawford and his wife owned stock in FDA-regulated companies -- including Wal-Mart; poultry biotechnology company Embrex; food and beverage maker PepsiCo; food distributor Sysco; and Kimberly-Clark, which makes some consumer health care products -- while he held senior positions at FDA but failed to disclose the holdings and made false statements about the couple's ownership of some of the stocks (Kaiser Daily Health Policy Report, 10/17).
Magistrate Judge Deborah Robinson accepted Crawford's guilty plea and scheduled a sentencing hearing for Jan. 22, 2007 (Stout, New York Times, 10/18).
After the arraignment, Crawford said, "This was my fault and no one else's," adding, "Nothing that I have done, I hope, can be construed to affect the integrity of the FDA" (AP/Philadelphia Inquirer, 10/18).
This article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente. |